Khonsu Therapeutics is a Cork-based high potential startup developing biologics to treat inflammation in veterinary & human health applications. We are developing an innovative recombinant version of a placenta protein for lameness & arthritis therapy in horses. The protein has anti-inflammatory & tissue repair activities that make it ideal for use in therapy. We are pursuing fast-track USDA approval to bring this drug to market within 2/3 years